AJP - Regu Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (June 1, 2006). doi:10.1152/ajpregu.00333.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/4/R861    most recent
00333.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reversi, A.
Right arrow Articles by Chini, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reversi, A.
Right arrow Articles by Chini, B.
Submitted on May 17, 2006
Accepted on May 19, 2006

Effects of cholesterol manipulation on the signalling of the human oxytocin receptor

Alessandra Reversi1, Valeria Rimoldi1, Silvia Brambillasca1, and Bice Chini1*

1 IN, CNR, Italy

* To whom correspondence should be addressed. E-mail: b.chini{at}in.cnr.it.

We have recently shown that oxytocin inhibits cell growth when the vast majority of oxytocin receptors (OTRs) are excluded from detergent-resistant membranes (DRMs, the biochemical counterpart of lipid rafts), but has a strong mitogenic effect when the receptors are targeted to these plasma membrane domains upon fusion with caveolin2, a resident raft protein. The aim of this study was to investigate whether the manipulation of total cell cholesterol can influence OTR localisation and signalling. Our data indicate that cholesterol depletion in HEK293 cells does not affect the signalling events mediated by the OTRs located outside DRMs: when treated with 2 mM methyl-{beta}-cyclodextrin (M{beta}CD), the receptors remained outside and continued to inhibit cell growth. On the contrary, the M{beta}CD treatment of cells expressing receptors fused to caveolin-2 led to their redistribution outside DRMs, and converted the receptor-mediated proliferative effect into cell growth inhibition. These data indicate that: 1) once released from DRMs, the receptors fused to caveolin2 signal are exactly the same as wild-type OTRs; and 2) their DRM location is responsible for the specific OTR signalling leading to cell proliferation. Finally, we evaluated whether cholesterol loading could force the OTRs into lipid rafts and change their signalling but, after cell treatment with an M{beta}CD/cholesterol complex, receptor stimulation continued to lead to cell growth inhibition, thus indicating that increasing cell cholesterol levels is not sufficient per se to affect OTR signalling.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.